Kohrn BF
No ORCID on file
· 3 papers in corpus
· active 2022-2024
Top journals
Frequent coauthors
- Risques RA 2
- Ghezelayagh TS 2
- Manhardt E 2
- Radke MR 2
- Norquist BM 2
- Katz R 2
- Fredrickson JU 1
- Fredrickson J 1
- Coombes C 1
- Gray HJ 1
2024
BackgroundIndividuals with germline BRCA1 and BRCA2 pathogenic variants (BRCA carriers) are at high risk of developing high grade serous ovarian carcinoma (HGSC). HGSC is predominantly driven by TP53 mutations, but mutations in this gene ar…
2022
BackgroundMore than 70% of leiomyomas (LM) harbor MED12 mutations, primarily in exon 2 at c.130-131(GG). The cause of MED12 mutations in myometrial cells remains largely unknown. We hypothesized that increased ROS promotes MED12 mutations i…
2022
Current screening methods for ovarian cancer (OC) have failed to demonstrate a significant reduction in mortality. Uterine lavage combined with TP53 ultra-deep sequencing for the detection of disseminated OC cells has emerged as a promising…